tm logo
TANVEX BIOSCIENCE
Live/Registered
REGISTERED

on 25 May 2021

Last Applicant/ Owned by

Hibiscus Way, 802 W Bay Rd.

Grand Cayman

KY

KY1-1205

Serial Number

87323897 filed on 03rd Feb 2017

Registration Number

6358663 registered on 25th May 2021

in the Principal Register

Correspondent Address

Dyan M. House

Dyan M. House

1900 N. Pearl Street

Suite 1500

Dallas, TX 75201

Filing Basis

1. intent to use

Disclaimer

NO DATA

TANVEX BIOSCIENCE

Anti-arthritis preparations; anti-inflammatory agent; anticancer drug; antirheumatic preparations; medicines for human purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Read More

Classification Information


Class [005]
Pharmaceutical Products


Anti-arthritis preparations; anti-inflammatory agent; anticancer drug; antirheumatic preparations; medicines for human purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis; western medicines for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis; medicinal agent for human use, namely, medicinal herbal preparations; biological preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis; haematogen, namely, blood substitutes for human use; chemical preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis; pharmaceutical drugs for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis; pharmaceutical preparations for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and ankylosing spondylitis

Mark Details


Serial Number

No 87323897

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 50300213

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th May 2021REGISTERED-PRINCIPAL REGISTER
09th Mar 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Mar 2021PUBLISHED FOR OPPOSITION
17th Feb 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Feb 20211(B) BASIS DELETED; NEW BASIS REQUESTED
04th Jan 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04th Jan 2021NOTICE OF ALLOWANCE CANCELLED
04th Jan 2021ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
04th Jan 2021ASSIGNED TO PETITION STAFF
18th Dec 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS